Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Curry leaf (Murraya koenigii) is rich in carbazole alkaloids—including mahanimbine, koenimbin, and girinimbine—that modulate glucose metabolism, suppress pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) via NF-κB pathway inhibition, and demonstrate significant anti-cancer potential through apoptosis induction in multiple cancer cell lines (PMID 33587002). A comprehensive 2021 review confirmed that all three curry leaf varieties (M. koenigii, Micromelum minutum, Clausena indica) possess validated antioxidant, antidiabetic, hepatoprotective, and cardioprotective properties supported by both traditional use and modern pharmacological evidence (PMID 34754314).
Reported Benefits (Provisional)
Origin & History
Murraya koenigii, commonly known as Curry Leaf, is an aromatic perennial tree native to India and Sri Lanka. Its distinctive leaves are widely cultivated across tropical and subtropical regions for both culinary and medicinal applications. Valued in traditional systems, Curry Leaf offers a rich profile of bioactive compounds that support diverse functional health benefits.
Research Narrative (Provisional)
A 2021 systematic review in Evidence-Based Complementary and Alternative Medicine evaluated the nutritive and therapeutic properties of three curry leaf varieties (M. koenigii, M. minutum, C. indica), confirming antioxidant, antidiabetic, and hepatoprotective activities across in vitro and animal models (PMID 34754314). A 2022 review in Nutrition and Cancer comprehensively assessed the anti-cancer potential of Murraya koenigii and its carbazole alkaloids, reporting dose-dependent cytotoxicity against breast, colon, leukemia, and liver cancer cell lines, with mahanimbine and girinimbine identified as the most potent constituents (PMID 33587002). A 2021 study in Experimental Gerontology examined natural leaf extracts including curry leaf for geriatric phytomedicine applications, finding significant neuroprotective and anti-aging effects mediated by antioxidant enzyme upregulation and mitochondrial membrane stabilization (PMID 33894308). These findings collectively substantiate curry leaf's traditional Ayurvedic uses with rigorous modern pharmacological evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber: Supports digestive health and gut microbiota. - Vitamins: Vitamin A (beta-carotene), Vitamin C, Vitamin E, B Vitamins (e.g., B1, B2, B3, B9). - Minerals: Iron, Calcium, Magnesium, Potassium. - Phytochemicals/Bioactives: - Carbazole Alkaloids (e.g., mahanimbine, girinimbine): Exhibit anti-inflammatory, antimicrobial, and neuroprotective effects. - Flavonoids & Polyphenols: Potent antioxidants that combat oxidative stress and inflammation. - Saponins: Contribute to cholesterol-lowering and immune-modulating properties. - Terpenes & Glycosides: Support metabolic regulation and hepatic detoxification.
Reported Mechanism (Provisional)
Curry leaf's primary bioactive carbazole alkaloids—mahanimbine, koenimbin, girinimbine, and murrayazoline—exert multi-target pharmacological effects: mahanimbine inhibits acetylcholinesterase (AChE) and activates AMPK signaling to enhance insulin-mediated glucose uptake in skeletal muscle and adipose tissue, while girinimbine induces intrinsic apoptosis in cancer cells through mitochondrial cytochrome c release and caspase-3/9 activation (PMID 33587002). The polyphenolic fraction demonstrates potent DPPH and ABTS radical scavenging activity strongly correlated with total phenolic content (R² = 0.92), suppressing NF-κB nuclear translocation and downstream transcription of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in LPS-stimulated RAW 264.7 macrophages (PMID 34754314). Additionally, the essential oil fraction—rich in linalool, α-pinene, and β-caryophyllene—modulates CYP450 hepatic detoxification enzymes (particularly CYP1A1 and CYP2B1), enhancing phase I and phase II biotransformation while promoting bile acid secretion through farnesoid X receptor (FXR) activation. These synergistic pathways underpin curry leaf's validated antidiabetic, anti-inflammatory, hepatoprotective, and anticancer properties.
Clinical Narrative (Provisional)
Current evidence consists primarily of in vitro and animal studies, with no published randomized controlled trials in humans. In vitro anticancer studies show cytotoxic activity against MDA-MB-231 breast cancer cells with IC₅₀ values ranging from 103.4-194.3 μg/mL depending on geographical origin of the extract. Animal studies demonstrate reduced inflammatory markers in 4T1 breast cancer-challenged mice, with significant IL-1β and IL-6 suppression. Human clinical trials are needed to validate the extensive preclinical findings and establish therapeutic dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.